Sulfametopyrazine

Also known as: Sulphaline, Sulphametopyrazina

Drug #2052

Sulfametopyrazine is a long acting sulfonamides that is used to treat certain infections caused by gram +ve and gram -ve bacteria.

← Previous drug Next drug →

Primary Characteristics

Sulfametopyrazine is also known as Sulphaline, Sulphametopyrazina.

Molecular Weight: 280.3 · Non-proprietary name: Sulfametopyrazine.

Molecular structure of Sulfametopyrazine

Pharmacokinetics

Distribution: Sulfametopyrazine has a plasma protein binding is 60-80%.

Elimination: plasma half-life is 60-65 hours.

Indications

Sulfametopyrazine is primarily indicated in conditions like Chronic bronchitis, Urinary tract infection.

Contraindications

Sulfametopyrazine is contraindicated in conditions like Allergy, Hypersensitivity.

Dosage

None recorded.

Drug Interactions

2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Sulfametopyrazine in overdosage may give rise to further complications which include Stevens johnson syndrome , Epidermal necrolysis , Dermatitis , Hematuria, Anuria.

The signs and symptoms that are produced after acute overdosage of Sulfametopyrazine are Fever, Rashes , Pruritus , Nephritis.

Sulfametopyrazine is known to cause more or less tolerable side effects which are usually transient. These include Anorexia , Diarrhea, Nausea, Vomiting .

Warnings / Precautions

In patients with it adequate fluid intake is necessary to reduce risk of crystalluria. It should be discontinued immediately if rash appears. It should be given with care to patients with severe hepatic or renal failure.allergy,asthma.

Available Brands

None recorded.

Storage Conditions

Sulfametopyrazine should be stored Tabs.

Drug Classification

1.6.4.3 — Antimalarials